Denmark has temporarily suspended the AstraZeneca coronavirus vaccine as a precautionary measure due to cases of blood clots in people who received it.
The country however said the connection has not yet been established and investigations are ongoing.
Norway and Iceland are some of the few countries in Europe that have joined Denmark by suspending the use of the AstraZeneca coronavirus vaccine.
As of March 9, 22 cases of blood clots had been reported among more than three million people vaccinated in the European Economic Area, the European Medicines Agency (EMA) said.
Austria announced on Monday that it had suspended the use of a batch of AstraZeneca vaccines after a 49-year-old nurse died of “severe blood coagulation problems” days after receiving an anti-Covid shot.
Four other European countries — Estonia, Latvia, Lithuania and Luxemburg — have also suspended the use of vaccines from this batch, which was sent to 17 European countries and consisted of one million jabs.
Denmark however suspended the use of all of its AstraZeneca supply, as did Iceland and Norway in subsequent announcements on Thursday citing similar concerns.
On Wednesday, the EMA said a preliminary probe showed that the batch of AstraZeneca vaccines used in Austria was likely not to blame for the nurse’s death.
“This is a super-cautious approach based on some isolated reports in Europe,” said Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine.
“The risk and benefit balance is still very much in favour of the vaccine,” he said.
AstraZeneca, an Anglo-Swedish company that developed the vaccine with Oxford University, defended the safety of its product.
“The safety of the vaccine has been extensively studied in phase III clinical trials and peer-reviewed data confirms the vaccine has been generally well-tolerated,” a spokesman for the group told AFP.
Source: The Precision with additional report from the Jakarta Post.
